EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	445	816	119	352	94	168
Market Cap Growth	921.34%	584.05%	-66.13%	272.92%	-43.65%	49.12%
Enterprise Value	163	490	20	179	90	195
PE Ratio	-	-11.53	-1.17	-6.03	-2.08	-2.95
PS Ratio	9.16	17.73	2.88	9.53	2.74	8.23
PB Ratio	1.83	3.06	1.24	1.91	5.09	20.12
P/FCF Ratio	-61.85	-507.46	-1.78	-7.01	-6.38	-2.94
P/OCF Ratio	-82.66	435.20	-1.84	-7.03	-6.54	-2.96
EV/Sales Ratio	3.27	10.64	0.49	4.84	2.60	9.59
EV/EBITDA Ratio	-9.46	-7.10	-0.21	-3.57	-2.53	-4.07
EV/EBIT Ratio	-9.38	-7.05	-0.21	-3.38	-2.35	-3.86
EV/FCF Ratio	-44.14	-304.54	-0.30	-3.56	-6.06	-3.43
Debt / Equity Ratio	0.02	0.02	0.47	0.21	2.17	6.02
Debt / EBITDA Ratio	-0.06	-0.07	-0.47	-0.77	-1.14	-1.04
Debt / FCF Ratio	-0.28	-3.05	-0.68	-0.76	-2.72	-0.88
Quick Ratio	4.83	5.25	4.64	9.72	3.66	2.93
Current Ratio	5.08	5.45	5.00	10.05	4.24	3.62
Asset Turnover	0.20	0.22	0.19	0.19	0.43	0.25
Interest Coverage	-180.22	-55.71	-31.06	-9.63	-5.26	-8.20
Return on Equity (ROE)	-49.90%	-61.50%	-74.20%	-46.80%	-388.00%	-314.00%
Return on Assets (ROA)	-30.90%	-33.50%	-46.50%	-29.30%	-57.00%	-69.90%
Return on Capital (ROIC)	-34.11%	-27.68%	-70.10%	-24.81%	-63.37%	-81.88%
Earnings Yield	-17.22%	-8.68%	-85.72%	-16.59%	-48.07%	-33.89%
FCF Yield	-3.63%	-0.20%	-56.30%	-14.27%	-15.67%	-33.96%
Buyback Yield / Dilution	-41.15%	-4.25%	-29.76%	-124.04%	-23.06%	-125.65%
Total Shareholder Return	-41.15%	-4.25%	-29.76%	-124.04%	-23.06%	-125.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).